EMEA-001136-PIP02-19-M01
Key facts
Invented name |
Doptelet
|
Active substance |
Avatrombopag
|
Therapeutic area |
Haematology-Hemostaseology
|
Decision number |
P/0482/2020
|
PIP number |
EMEA-001136-PIP02-19-M01
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of chemotherapy-induced thrombocytopenia
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Dova Pharmaceuticals Ireland Limited
E-mail: medical.info@sobi.com
Tel: +46 86972000 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|